Clinical Trials Logo

Hematologic Tests clinical trials

View clinical trials related to Hematologic Tests.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04778553 Completed - Hematologic Tests Clinical Trials

Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Start date: October 19, 2020
Phase:
Study type: Observational

This is a method comparison study for an in vitro diagnostic device. The device is a point of care automated hematology analyzer which measures CBC parameters with a small drop of venous or capillary, e.g., fingerstick blood. The study compared the CBC results from the test device, the Essenlix iMOST X-1 to the predicate laboratory based Horiba Pentra 60C+ analyzer. The CBC parameters were hemoglobin, White Blood Cells (WBC) and the WBC Differential for Granulocytes, Neutrophils, Lymphocytes and Monocytes. The study subjects were patient donors (age 18 and older) attending the hospital clinic from whom Informed Consent had been received.

NCT ID: NCT02936362 Completed - Clinical trials for Dietary Modification

Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals

Start date: February 2016
Phase: N/A
Study type: Interventional

Bread is the most common grain product in the world, with consumption surpassing 3 billion individuals per year. Sourdough whole-grain bread is considered a healthy alternative to white, refined-wheat bread. This cross-over study will test the effect of consumption of sourdough bread compared to white bread following a short dietary intervention period (one week) on multiple clinical parameters and gut microbiota.

NCT ID: NCT00768547 Completed - Hematologic Tests Clinical Trials

Risk Stratification in Acutely Admitted Medical Patients

Start date: August 2008
Phase: N/A
Study type: Observational

The study has three main parts. 1. To see if we can develop a riskstratification tool that can be used to asses the risk for acutely admitted medical patients for inhospital death, admission to the ICU and death within 30 days of release. 2. To test existing tool as in 1. 3. To clarify if it is most reasonable to let the admitting doctor order blood test by clinical judgment or be using a predefined list of tests.